Cargando…
Efficacy and Cost-Effectiveness of Anti-VEGF for Treating Diabetic Retinopathy in the Indian Population
PURPOSE: In the present study, we aimed to evaluate the efficacy, safety, and cost-effectiveness of the anti-vascular endothelial growth factor (anti-VEGF), namely ranibizumab (RBZ) or bevacizumab (BVZ), after either focal or grid or scatter laser photocoagulation, for the treatment of diabetic macu...
Autores principales: | Pramanik, Subhasish, Mondal, Lakshmi Kanta, Paine, Suman Kalyan, Jain, Sneha, Chowdhury, Subhankar, Ganguly, Upasana, Ghosh, Sayantan, Bose, Chiranjit, Bhattacharjee, Koena, Bhaduri, Gautam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364366/ https://www.ncbi.nlm.nih.gov/pubmed/34408392 http://dx.doi.org/10.2147/OPTH.S317771 |
Ejemplares similares
-
Do different lipid components accelerate the pathogenesis and severity of Diabetic Retinopathy?
por: Mondal, Lakshmi Kanta, et al.
Publicado: (2022) -
Visual contrast sensitivity could be an early marker of diabetic retinopathy
por: Pramanik, Subhasish, et al.
Publicado: (2020) -
Decreased Levels of miR-126 and miR-132 in Plasma and Vitreous Humor of Non-Proliferative Diabetic Retinopathy Among Subjects with Type-2 Diabetes Mellitus
por: Pramanik, Subhasish, et al.
Publicado: (2022) -
The Amelioration of Detrimental Biochemical Anomalies by Supplementing B, C, and E Vitamins in Subjects with Type 2 Diabetes Mellitus May Reduce the Rate of Development of Diabetic Retinopathy
por: Pramanik, Subhasish, et al.
Publicado: (2022) -
Biochemical scenario behind initiation of diabetic retinopathy in type 2 diabetes mellitus
por: Mondal, Lakshmi Kanta, et al.
Publicado: (2018)